References
- Singh N, Bhalla M, de Jager P, Gilca M, An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda, Afr J Tradit Complement Altern Med., 2011, 8(5 Suppl), p. 208–213, doi:10.4314/ajtcam. v8i5S.9.
- Kumar ST, Chand ACP, Adiga M., A REVIEW ON ADAPTOGENIC ACTIVITY OF ASHWAGANDHA (WITHANIA SOMNIFERA): AN AYURVEDIC APPRAISAL, Journal of Pharmaceutical & Scientific Innovation, 2017, 6(5), doi:10.7897/2277–4572.06561.
- Mikulska P., Malinowska M., Ignacyk M., et al., Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review, Pharmaceutics, 2023, 15(4), 1057, doi:10.3390/pharmaceutics15041057.
- Durg S., Shivaram SB, Bavage S., Withania somnifera (Indian ginseng) in male infertility: An evidence-based systematic review and meta-analysis, Phytomedicine, 2018, 50, p. 247–256, doi:10.1016/j. phymed.2017.11.011.
- Dutta R., Khalil R., Green R., Mohapatra SS., Mohapatra S., Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology, Int J Mol Sci, 2019, 20(21), doi:10.3390/ijms20215310.
- Tireki S., Ashwagandha, Rhodiola rosea and Maca as Adaptogens, Modern Concepts & Developments in Agronomy, 2021, 8(5), doi:10.31031/MCDA.2021.08.000696.
- Kumar S., Gill MK., Sharma M., Singh TP., Kumar K., Kaur R., Role of Ashwagandha Incorporated Functional Foods for Betterment of Human Health: A Review, Journal of Agricultural Engineering and Food Technology, 2019, 6(2).
- Mukherjee PK., Banerjee S., Biswas S., Das B., Kar A., Katiyar CK., Withania somnifera (L.) Dunal – Modern perspectives of an ancient Rasayana from Ayurveda, J Ethnopharmacol, 2021, 264, 113157, doi:10.1016/j.jep.2020.113157.
- Bhattacharya SK., Muruganandam AV, Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress, Pharmacol Biochem Behav., 2003, 75(3), p. 547–555, doi:10.1016/S0091–3057(03)00110–2.
- Archana R., Namasivayam A., Antistressor effect of Withania somnifera, J Ethnopharmacol., 1998, 64(1), p. 91–93, doi:10.1016/S0378–8741(98)00107-X.
- Majeed M., Nagabhushanam K., Mundkur L., A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study, Medicine, 2023, 102(41), e35521, doi:10.1097/MD.0000000000035521.
- Smith SJ., Lopresti AL., Fairchild TJ., Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial, Journal of Psychopharmacology, 2023, 37(11), p. 1091–1104, doi:10.1177/02698811231200023.
- Jain S., Pandhi P., Singh A., Malhotra S., Efficacy of standardised herbal extracts in type 1 diabetes – an experimental study, African Journal of Traditional, Complementary and Alternative Medicines, 2006, 3(4), doi:10.4314/ajtcam.v3i4.31174.
- Kyathanahalli CN., Manjunath MJ., Muralidhara, Oral supplementation of standardized extract of Withania somnifera protects against diabetes-induced testicular oxidative impairments in prepubertal rats, Protoplasma, 2014, 251(5), p. 1021–1029, doi:10.1007/s00709–014–0612–5.
- K. Thakur A., Dey A., S. Chatterjee S., Kumar V., Reverse Ayurvedic Pharmacology of Ashwagandha as an Adaptogenic Anti-Diabetic Plant: A Pilot Study, Current Traditional Medicine, 2015, 1(1), p. 51–61, doi:10.2174/2215083801999150527115205.
- Udayakumar R., Kasthurirengan S., Mariashibu TS., et al., Hypoglycaemic and Hypolipidaemic Effects of Withania somnifera Root and Leaf Extracts on Alloxan-Induced Diabetic Rats., Int J Mol Sci., 2009, 10(5), p. 2367–2382, doi:10.3390/ijms10052367.
- Tekula S., Khurana A., Anchi P., Godugu C., Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes, Biomedicine & Pharmacotherapy, 2018, 106, p. 1428–1440, doi:10.1016/j.biopha.2018.07.090.
- Kempegowda PK., Zameer F., Kumar Murari S., Delineating antidiabetic proficiency of catechin from Withania somnifera and its Inhibitory action on dipeptidyl peptidase-4 (DPP-4), Biomedical Research, 2018, 29(16), doi:10.4066/biomedicalresearch.29–18–922.
- Udayakumar R., Kasthurirengan S., Vasudevan A., et al., Antioxidant Effect of Dietary Supplement Withania somnifera L. Reduce Blood Glucose Levels in Alloxan-Induced Diabetic Rats, Plant Foods for Human Nutrition, 2010, 65(2), p. 91–98, doi:10.1007/s11130–009–0146–8.
- Agnihotri A., Sontakke S., Thawani V., Saoji A., Goswami VS., Effects of Withania somnifera in patients of schizophrenia: A randomized, double blind, placebo controlled pilot trial study, Indian J Pharmacol., 2013, 45(4), 417, doi:10.4103/0253–7613.115012.
- Mohanty IR, Arya DS, Gupta SK. Withania somnifera provides cardioprotection and attenuates ischemia–reperfusion induced apoptosis, Clinical Nutrition, 2008, 27(4), p. 635–642, doi:10.1016/j. clnu.2008.05.006.
- Khalil MdI., Ahmmed I., Ahmed R., et al., Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract, Biomed Res Int., 2015, 2015, p. 1–10, doi:10.1155/2015/624159.
- Guo R., Gan L., Lau WB., et al., Withaferin A Prevents Myocardial Ischemia/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling, Circulation Journal, 2019, 83(8), p. 1726–1736, doi:10.1253/circj.CJ-18–1391.
- Rasool M., Varalakshmi P., Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study, Vascul Pharmacol. 2006, 44(6), p. 406–410, doi:10.1016/j.vph.2006.01.015.
- Alenazi F., Moursi S., Mahmoud MR., et al., Withaferin A alleviates inflammation in animal models of arthritis by inhibiting the NF-κB pathway and cytokine release, Chem Biol Interact., 2024, 398, 111114, doi:10.1016/j.cbi.2024.111114.
- Kanjilal S., Gupta AK., Patnaik RS., Dey A., Analysis of Clinical Trial Registry of India for Evidence of Anti-Arthritic Properties of Withania somnifera (Ashwagandha)., Altern Ther Health Med., 2021, 27(6), p. 58–66.
- Sikandan A., Shinomiya T., Nagahara Y., Ashwagandha root extract exerts antiinflammatory effects in HaCaT cells by inhibiting the MAPK/NFκB pathways and by regulating cytokines, Int J Mol Med., 2018, doi:10.3892/ijmm.2018.3608.
- Shivu ME., Gupta N., Mulla M., Mulla M., Anand Bajoria A., Varshney A., Evaluation of Turmeric, Ashwagandha, and Aloe Vera in the Management of Oral Lichen Planus Lesion, J Pharm Bioallied Sci., 2024, 16(Suppl3), S2043-S2045, doi:10.4103/jpbs.jpbs_1264_23.
- Kuttan G., Use of Withania somnifera Dunal as an adjuvant during radiation therapy, Indian J Exp Biol., 1996, 34(9), p. 854–856.
- Muralikrishnan G., Dinda AK., Shakeel F., Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice, Immunol Invest., 2010, 39(7), p. 688–698, doi:10.3109/08820139.2010.487083.
- Davis L., Kuttan G., Immunomodulatory activity of Withania somnifera, J Ethnopharmacol., 2000, 71(1–2), p. 193–200, doi:10.1016/s0378–8741(99)00206–8.
- Tharakan A., Shukla H., Benny IR., Tharakan M., George L., Koshy S., Immunomodulatory Effect of Withania somnifera (Ashwagandha) Extract-A Randomized, Double-Blind, Placebo Controlled Trial with an Open Label Extension on Healthy Participants, J Clin Med., 2021, 10(16), doi:10.3390/ jcm10163644.
- Sumathi S., Padma PR., Gathampari S., Vidhya S., Free radical scavenging activity of different parts of withania somnifera, Anc Sci Life, 2007, 26(3), p. 30–34.
- Dhuley JN., Effect of ashwagandha on lipid peroxidation in stress-induced animals, J Ethnopharmacol., 1998, 60(2), p. 173–178, doi:10.1016/s0378–8741(97)00151–7.
- Passeri E., Elkhoury K., Morsink M., et al., Alzheimer’s Disease: Treatment Strategies and Their Limitations, Int J Mol Sci., 2022, 23(22). doi:10.3390/ijms232213954.
- Kurapati KRV., Atluri VSR., Samikkannu T., Nair MPN., Ashwagandha (Withania somnifera) reverses β-amyloid1–42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND), PLoS One. 2013, 8(10), e77624, doi:10.1371/journal.pone.0077624.
- Murthy MN., Shyamala BV., Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuro-protective remedy for genetically induced motor dysfunction and cellular toxicity in human neurode-generative disease models of Drosophila., J Ethnopharmacol., 2024, 318(Pt A), 116897, doi:10.1016/j. jep.2023.116897.
- Ahmad M., Saleem S., Ahmad AS., et al., Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats, Hum Exp Toxicol., 2005, 24(3), p. 137–147, doi:10.1191/0960327105ht509oa.
- RajaSankar S., Manivasagam T., Sankar V., et al., Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson’s disease model mouse, J Ethnopharmacol., 2009, 125(3), p. 369–373, doi:10.1016/j.jep.2009.08.003.
- Sankar SR., Manivasagam T., Krishnamurti A., Ramanathan M., The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables, Cell Mol Biol Lett., 2007, 12(4), p. 473–481, doi:10.2478/s11658–007–0015–0.
- Schliebs R., Liebmann A., Bhattacharya SK., Kumar A., Ghosal S., Bigl V., Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain, Neurochem Int., 1997, 30(2), p. 181–190, doi:10.1016/s0197–0186(96)00025–3.
- 42. Das R., Rauf A., Akhter S., et al., Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives, Molecules, 2021, 26(12), doi:10.3390/ molecules26123696.
- Mehta V., Chander H., Munshi A., Mechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha), Nutr Cancer., 2021, 73(6), p. 914–926, doi:10.1080/01635581.2020.1778746.
- Kapoor S., Gupta N., Sharma A., A Polyherbal Ashwagandha Formulation Exhibits Adjunctive Antitumor Efficacy Against U266 Myeloma Cells by Multi-Strategic Cytotoxic Effects: An Experimental Approach, Asian Pac J Cancer Prev., 2023, 24(11), p. 3705–3714, doi:10.31557/ APJCP.2023.24.11.3705.
- Yang ES., Choi MJ., Kim JH., Choi KS., Kwon TK., Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition, Chem Biol Interact, 2011, 190(1), p. 9–15, doi:10.1016/j.cbi.2011.01.015.
- Mayola E., Gallerne C., Esposti DD., et al., Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2, Apoptosis, 2011, 16(10), p. 1014–1027, doi:10.1007/s10495–011–0625-x.
- Yang ES., Choi MJ., Kim JH., Choi KS., Kwon TK., Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells, Toxicol In Vitro, 2011, 25(8), p. 1803–1810, doi:10.1016/j. tiv.2011.09.016.
- Mahdi AA., Shukla KK., Ahmad MK., et al.. Withania somnifera Improves Semen Quality in Stress-Related Male Fertility, Evid Based Complement Alternat Med., 2009, 2011, doi:10.1093/ecam/nep138.
- Nasimi Doost Azgomi R., Nazemiyeh H., Sadeghi Bazargani H., et al., Comparative evaluation of the effects of Withania somnifera with pentoxifylline on the sperm parameters in idiopathic male infertility: A triple-blind randomised clinical trial, Andrologia, 2018, 50(7), e13041, doi:10.1111/and.13041.
- Gupta A., Mahdi AA., Shukla KK., et al., Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: a proton NMR study at 800 MHz. J Ethnopharmacol., 2013, 149(1), p. 208–214, doi:10.1016/j.jep.2013.06.024.
- Połumackanycz M., Forencewicz A., Wesołowski M., Viapiana A., Ashwagandha (Withania somnifera L.) – the plant with proven health-promoting properties, Farm Pol. 2020, 76(8), p. 442–447, doi:10.32383/farmpol/127824.
- Abdel-Wahhab KG., Mourad HH., Mannaa FA., Morsy FA., Hassan LK., Taher RF., Role of ashwagandha methanolic extract in the regulation of thyroid profile in hypothyroidism modeled rats, Mol Biol Rep., 2019, 46(4), p. 3637–3649, doi:10.1007/s11033–019–04721-x.
- Sharma AK., Basu I., Singh S., Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial., J Altern Complement Med., 2018, 24(3), p. 243–248, doi:10.1089/acm.2017.0183.
- van der Hooft CS., Hoekstra A., Winter A., de Smet PAG, Stricker BHC. [Thyrotoxicosis following the use of ashwagandha], Ned Tijdschr Geneeskd., 2005, 149(47), p. 2637–2638.
- Hayashi M., Hamada H., Azuma SI., Hayashi K., Painless Thyroiditis by Withania somnifera (Ashwagandha), Cureus, 2024, 16(3), e55352, doi:10.7759/cureus.55352.
- Kamal HI., Patel K., Brdak A., Heffernan J., Ahmad N., Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia, Cureus, 2022, 14(3), e23494, doi:10.7759/cureus.23494.
- Bisht P., Rawat V., Antibacterial activity of Withania somnifera against Gram-positive isolates from pus samples, Ayu., 2014, 35(3), p. 330–332, doi:10.4103/0974–8520.153757.
- Singh G., Kumar P., Evaluation of antimicrobial efficacy of flavonoids of withania somnifera L., Indian J Pharm Sci., 2011, 73(4), p. 473–478, doi:10.4103/0250–474X.95656.
- Alam N., Hossain M., Mottalib MA., Sulaiman SA., Gan SH., Khalil MI., Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities, BMC Complement Altern Med., 2012, 12, 175, doi:10.1186/1472–6882–12–175.
- Owais M,, Sharad KS,, Shehbaz A,, Saleemuddin M.. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis, Phytomedicine, 2005, 12(3), p. 229–235, doi:10.1016/j.phymed.2003.07.012.
- Pandit S., Chang KW., Jeon JG., Effects of Withania somnifera on the growth and virulence properties of Streptococcus mutans and Streptococcus sobrinus at sub-MIC levels, Anaerobe, 2013, 19, p. 1–8, doi:10.1016/j.anaerobe.2012.10.007.
- Chandrasekaran S., Dayakar A., Veronica J., Sundar S., Maurya R., An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides, Parasitol Int., 2013, 62(3), p. 253–261, doi:10.1016/j.parint.2013.01.007.
- Murugan R., Rajesh R., Seenivasan B., et al., Withaferin A targets the membrane of Pseudomonas aeruginosa and mitigates the inflammation in zebrafish larvae; an in vitro and in vivo approach, Microb Pathog., 2022, 172, 105778, doi:10.1016/j.micpath.2022.105778.
- Durmer JS., Dinges DF., Neurocognitive consequences of sleep deprivation, Semin Neurol., 2005, 25(1), p. 117–129, doi:10.1055/s-2005–867080.
- Suganya K., Kayalvizhi E., Yuvaraj R., Chandrasekar M., Kavitha U., Konakanchi Suresh K., Effect of Withania Somnifera on the antioxidant and neurotransmitter status in sleep deprivation induced Wistar rats, Bioinformation, 2020, 16(8), p. 631–637, doi:10.6026/97320630016631.
- Deshpande A., Irani N., Balkrishnan R., Benny IR., A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults, Sleep Med., 2020, 72, p. 28–36, doi:10.1016/j.sleep.2020.03.012.
- Kelgane SB., Salve J., Sampara P., Debnath K., Efficacy and Tolerability of Ashwagandha Root Extract in the Elderly for Improvement of General Well-being and Sleep: A Prospective, Randomized, Double-blind, Placebo-controlled Study, Cureus, 2020, 12(2), e7083, doi:10.7759/cureus.7083.
- Park CW., Hong KB., Suh HJ., Ahn Y., Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via GABA receptors, J Food Drug Anal,. 2023, 31(2), p. 278–288, doi:10.38212/2224–6614.3456.
- Yidya Prabhu M., Rao A., Karanth KS., Neuropharmacological activity of Withania somnifera, Fitoterapia, 1990, 61(3).
- Ilayperuma I., Ratnasooriya WD., Weerasooriya TR., Effect of Withania somnifera root extract on the sexual behaviour of male rats, Asian J Androl., 2002, 4(4), p. 295–298.
- Dhuley JN., Adaptogenic and cardioprotective action of ashwagandha in rats and frogs, J Ethnopharmacol., 2000, 70(1), p. 57–63, doi:10.1016/s0378–8741(99)00177–4.
- Sharada AC., Solomon FE., Devi PU., Toxicity of withania somnifera root extract in rats and mice, Pharm Biol., 1993, 31(3), doi:10.3109/13880209309082943.
- Tóth M., Benedek AE., Longerich T., Seitz HK., Ashwagandha-induced acute liver injury: A case report, Clin Case Rep., 2023, 11(3), e7078, doi:10.1002/ccr3.7078.
- Lubarska M., Hałasiński P., Hryhorowicz S., et al., Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury, Int J Environ Res Public Health, 2023, 20(5), doi:10.3390/ ijerph20053921.
- Savai J., Varghese A., Pandita N., Chintamaneni M., Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes, Phytother Res., 2015, 29(5), p. 785–790, doi:10.1002/ptr.5308.
- Akhgarjand C., Asoudeh F., Bagheri A., et al., Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials, Phytother Res., 2022, 36(11), p. 4115–4124, doi:10.1002/ptr.7598.
- Singh M., Bhasin S., Singh D., Shruti Bhasin C., Review on bioactive metabolites of Withania somnifera. (L.), Dunal and its pharmacological significance, J Pharmacogn Phytochem., 2019, 8(3).